The Successful Ventures network of business angels is moving into the digital health arena by investing and joining the board at Devicare. The Inveniam Group has guided Devicare in this round.

The company founded by Rosendo Garganta is a leader in research and development of innovative solutions for urology conditions, and will put the investment towards internationalisation of Lit-Control® after having signed 45 distribution deals in Europe, the Middle East, Latin America and the United States.

Recently the University of the Balearic Islands and Devicare patented a compound that prevents the calcification of ureteral catheters and bladder catheters.

“We’re very excited about this investment due to Devicare’s market penetration and lack of competition,” noted Fran Piera, administrator of Successful Ventures.

For his part, Rosendo Garganta noted that “Successful Ventures’ experience in legal consulting and analysis for technology start-ups and alliances with international investment funds make it a strategic partner that brings us value added.”

Successful Ventures has over 100 active investors and invested €1.8 million in 15 technology-based start-ups in 2019.

More information

Photo: Rosendo Garganta, founder and CEO of Devicare

You may also be interested in:

• Devicare closes a round of more than €1.6 million in Capital Cell
• Devicare announces the positive results of the clinical trial with Lit-Control® to prevent the encrustation of catheters